000650.SZ
Strong BuyFull HouseRenhe Pharmacy Co.,Ltd · Healthcare · China · $1.1B
CNY 5.24 +1.9% · close 30 Sep · scored 7 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT RENHE PHARMACY CO.,LTD
Read
Renhe Pharmacy is a prominent pharmaceutical company specializing in the manufacture and distribution of over-the-counter (OTC) medicines, traditional Chinese medicines, and healthcare products. The company possesses a highly recognized brand portfolio and an extensive distribution network covering hundreds of thousands of retail pharmacies across China. It operates as a highly resilient, marketing-driven consumer healthcare leader with stable cash flows.
FINANCIAL SUMMARY (CNY)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 5.2B | 5.0B | 4.1B | 3.5B | -11.8% | 3.6B |
| EPS (CNY) | 0.41 | 0.41 | 0.35 | 0.28 | -11.9% | 0.28 |
| Shares | 1.4B | 1.4B | 1.4B | 1.4B | 0.0% | 1.4B |
| Debt | 12.5M | 5.8M | 2.6M | 2.2M | -43.8% | 2.2M |
| Equity | 5.7B | 6.0B | 6.2B | 6.3B | 3.2% | — |
| Op CF | 1.3B | 499.5M | 557.3M | 851.3M | -12.5% | 750.8M |
| Inv CF | -575.2M | -294.0M | -462.4M | -98.3M | — | — |
| Fin CF | -230.1M | -416.1M | -383.8M | -304.6M | — | — |
Calmer than 84% of stocks we rank over the past year (24% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000650.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000650.SZ | Renhe Pharmacy Co.,Ltd(you) | $1.1B | 95 | Strong Buy |
| 600479.SS | ZhuZhou QianJin Pharmaceutical Co.,Ltd | $909M | 93 | Strong Buy |
| 002275.SZ | Guilin Sanjin Pharmaceutical Co., Ltd. | $1.1B | 89 | Strong Buy |
| 000989.SZ | Jiuzhitang Co., Ltd. | $1.1B | 89 | Strong Buy |
| 000915.SZ | Shandong Wit Dyne Health Co.,Ltd. | $837M | 98 | Strong Buy |
| 603367.SS | Cisen Pharmaceutical Co., Ltd. | $963M | 87 | Strong Buy |
| 2877.HK | China Shineway Pharmaceutical Group Limited | $791M | 99 | Strong Buy |
| 002332.SZ | Zhejiang Xianju Pharmaceutical Co., Ltd. | $1.3B | 87 | Strong Buy |
| 1681.HK | Consun Pharmaceutical Group Limited | $1.5B | 99 | Strong Buy |
| 600572.SS | Zhejiang CONBA Pharmaceutical Co.,Ltd. | $1.6B | 91 | Strong Buy |
Peer medians: ROE 4.3% · P/E 27.8x · Gross margin 53.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.